{"entity":{"type":"insider","cik":"0001796309","url":"/insider/0001796309","json_url":"/insider/0001796309.json","name":"Salzmann Peter","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":41,"n_filings":33,"first":"2022-01-11","last":"2025-04-17","span_basis":"filed_date"},"name_variants":[{"name":"Salzmann Peter","source":"filing","n_filings":33,"first_seen":"2022-01-11","last_seen":"2025-04-17"}],"transactions":[{"id":4037750,"accession":"0001764013-25-000075","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-25-000075","line_url":"/filing/0001764013-25-000075#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796309","owner_name":"Salzmann Peter","owner_display_name":"Salzmann Peter","owner_url":"/insider/0001796309","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8321.0,"shares_display":"8,321","price_per_share":14.89,"price_display":"14.89","price_state":"stated","total_value":123899.69,"total_display":"123,899.69","total_whole":"123,900","shares_owned_after":1178191.0,"shares_owned_after_display":"1,178,191","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-16","filed_date":"2025-04-17","scope":"insider"},{"id":4896798,"accession":"0001764013-25-000066","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-25-000066","line_url":"/filing/0001764013-25-000066#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796309","owner_name":"Salzmann Peter","owner_display_name":"Salzmann Peter","owner_url":"/insider/0001796309","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28094.0,"shares_display":"28,094","price_per_share":12.99,"price_display":"12.99","price_state":"stated","total_value":364941.06,"total_display":"364,941.06","total_whole":"364,941","shares_owned_after":1186512.0,"shares_owned_after_display":"1,186,512","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-09","filed_date":"2025-04-11","scope":"insider"},{"id":4252173,"accession":"0001764013-25-000030","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-25-000030","line_url":"/filing/0001764013-25-000030#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796309","owner_name":"Salzmann Peter","owner_display_name":"Salzmann Peter","owner_url":"/insider/0001796309","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15439.0,"shares_display":"15,439","price_per_share":20.86,"price_display":"20.86","price_state":"stated","total_value":322057.54,"total_display":"322,057.54","total_whole":"322,058","shares_owned_after":948786.0,"shares_owned_after_display":"948,786","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-19","filed_date":"2025-02-21","scope":"insider"},{"id":4252169,"accession":"0001764013-25-000013","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001764013-25-000013","line_url":"/filing/0001764013-25-000013","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796309","owner_name":"Salzmann Peter","owner_display_name":"Salzmann Peter","owner_url":"/insider/0001796309","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8767.0,"shares_display":"8,767","price_per_share":23.827987909204975,"price_display":"23.83","price_state":"stated","total_value":208899.97,"total_display":"208,899.97","total_whole":"208,900","shares_owned_after":964640.0,"shares_owned_after_display":"964,640","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-15","filed_date":"2025-01-17","scope":"insider","n_lines":2},{"id":4440137,"accession":"0001764013-25-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-25-000003","line_url":"/filing/0001764013-25-000003#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796309","owner_name":"Salzmann Peter","owner_display_name":"Salzmann Peter","owner_url":"/insider/0001796309","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5105.0,"shares_display":"5,105","price_per_share":24.1,"price_display":"24.10","price_state":"stated","total_value":123030.5,"total_display":"123,030.50","total_whole":"123,031","shares_owned_after":972992.0,"shares_owned_after_display":"972,992","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-08","filed_date":"2025-01-10","scope":"insider"},{"id":2747777,"accession":"0001764013-24-000193","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-24-000193","line_url":"/filing/0001764013-24-000193#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796309","owner_name":"Salzmann Peter","owner_display_name":"Salzmann Peter","owner_url":"/insider/0001796309","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16692.0,"shares_display":"16,692","price_per_share":25.45,"price_display":"25.45","price_state":"stated","total_value":424811.4,"total_display":"424,811.40","total_whole":"424,811","shares_owned_after":978097.0,"shares_owned_after_display":"978,097","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-20","filed_date":"2024-11-22","scope":"insider"},{"id":3101291,"accession":"0001764013-24-000174","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-24-000174","line_url":"/filing/0001764013-24-000174#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796309","owner_name":"Salzmann Peter","owner_display_name":"Salzmann Peter","owner_url":"/insider/0001796309","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9095.0,"shares_display":"9,095","price_per_share":28.79,"price_display":"28.79","price_state":"stated","total_value":261845.05,"total_display":"261,845.05","total_whole":"261,845","shares_owned_after":994789.0,"shares_owned_after_display":"994,789","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-16","filed_date":"2024-10-18","scope":"insider"},{"id":2707991,"accession":"0001764013-24-000165","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-24-000165","line_url":"/filing/0001764013-24-000165#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796309","owner_name":"Salzmann Peter","owner_display_name":"Salzmann Peter","owner_url":"/insider/0001796309","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4460.0,"shares_display":"4,460","price_per_share":29.56,"price_display":"29.56","price_state":"stated","total_value":131837.6,"total_display":"131,837.60","total_whole":"131,838","shares_owned_after":1003884.0,"shares_owned_after_display":"1,003,884","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-09","filed_date":"2024-10-11","scope":"insider"},{"id":2832130,"accession":"0001764013-24-000156","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001764013-24-000156","line_url":"/filing/0001764013-24-000156","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796309","owner_name":"Salzmann Peter","owner_display_name":"Salzmann Peter","owner_url":"/insider/0001796309","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15068.0,"shares_display":"15,068","price_per_share":31.859049641624637,"price_display":"31.86","price_state":"stated","total_value":480052.16,"total_display":"480,052.16","total_whole":"480,052","shares_owned_after":1008942.0,"shares_owned_after_display":"1,008,942","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-21","filed_date":"2024-08-23","scope":"insider","n_lines":2},{"id":2925385,"accession":"0001764013-24-000133","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001764013-24-000133","line_url":"/filing/0001764013-24-000133","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796309","owner_name":"Salzmann Peter","owner_display_name":"Salzmann Peter","owner_url":"/insider/0001796309","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8685.0,"shares_display":"8,685","price_per_share":29.693436960276337,"price_display":"29.69","price_state":"stated","total_value":257887.5,"total_display":"257,887.50","total_whole":"257,888","shares_owned_after":1023922.0,"shares_owned_after_display":"1,023,922","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-17","filed_date":"2024-07-19","scope":"insider","n_lines":2},{"id":3139416,"accession":"0001764013-24-000125","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-24-000125","line_url":"/filing/0001764013-24-000125#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796309","owner_name":"Salzmann Peter","owner_display_name":"Salzmann Peter","owner_url":"/insider/0001796309","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4619.0,"shares_display":"4,619","price_per_share":28.06,"price_display":"28.06","price_state":"stated","total_value":129609.14,"total_display":"129,609.14","total_whole":"129,609","shares_owned_after":1032097.0,"shares_owned_after_display":"1,032,097","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-09","filed_date":"2024-07-10","scope":"insider"},{"id":2873675,"accession":"0001764013-24-000098","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-24-000098","line_url":"/filing/0001764013-24-000098#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796309","owner_name":"Salzmann Peter","owner_display_name":"Salzmann Peter","owner_url":"/insider/0001796309","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16163.0,"shares_display":"16,163","price_per_share":29.65,"price_display":"29.65","price_state":"stated","total_value":479232.95,"total_display":"479,232.95","total_whole":"479,233","shares_owned_after":1036716.0,"shares_owned_after_display":"1,036,716","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-22","filed_date":"2024-05-24","scope":"insider"},{"id":2873671,"accession":"0001764013-24-000075","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001764013-24-000075","line_url":"/filing/0001764013-24-000075","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796309","owner_name":"Salzmann Peter","owner_display_name":"Salzmann Peter","owner_url":"/insider/0001796309","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34079.0,"shares_display":"34,079","price_per_share":29.05804630417559,"price_display":"29.06","price_state":"stated","total_value":990269.16,"total_display":"990,269.16","total_whole":"990,269","shares_owned_after":1060593.0,"shares_owned_after_display":"1,060,593","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-17","filed_date":"2024-04-19","scope":"insider","n_lines":2},{"id":2261038,"accession":"0001764013-24-000069","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-24-000069","line_url":"/filing/0001764013-24-000069#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796309","owner_name":"Salzmann Peter","owner_display_name":"Salzmann Peter","owner_url":"/insider/0001796309","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4807.0,"shares_display":"4,807","price_per_share":31.18,"price_display":"31.18","price_state":"stated","total_value":149882.26,"total_display":"149,882.26","total_whole":"149,882","shares_owned_after":1086958.0,"shares_owned_after_display":"1,086,958","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-09","filed_date":"2024-04-10","scope":"insider"},{"id":2616373,"accession":"0001764013-24-000037","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-24-000037","line_url":"/filing/0001764013-24-000037#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796309","owner_name":"Salzmann Peter","owner_display_name":"Salzmann Peter","owner_url":"/insider/0001796309","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13454.0,"shares_display":"13,454","price_per_share":36.15,"price_display":"36.15","price_state":"stated","total_value":486362.1,"total_display":"486,362.10","total_whole":"486,362","shares_owned_after":931231.0,"shares_owned_after_display":"931,231","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-22","filed_date":"2024-02-23","scope":"insider"},{"id":2366915,"accession":"0001764013-24-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-24-000006","line_url":"/filing/0001764013-24-000006#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796309","owner_name":"Salzmann Peter","owner_display_name":"Salzmann Peter","owner_url":"/insider/0001796309","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3824.0,"shares_display":"3,824","price_per_share":38.59,"price_display":"38.59","price_state":"stated","total_value":147568.16,"total_display":"147,568.16","total_whole":"147,568","shares_owned_after":944685.0,"shares_owned_after_display":"944,685","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-05","filed_date":"2024-01-09","scope":"insider"},{"id":8662817,"accession":"0001764013-23-000146","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001764013-23-000146","line_url":"/filing/0001764013-23-000146","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796309","owner_name":"Salzmann Peter","owner_display_name":"Salzmann Peter","owner_url":"/insider/0001796309","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16217.0,"shares_display":"16,217","price_per_share":32.779248319664546,"price_display":"32.78","price_state":"stated","total_value":531581.07,"total_display":"531,581.07","total_whole":"531,581","shares_owned_after":949125.0,"shares_owned_after_display":"949,125","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-22","filed_date":"2023-11-24","scope":"insider","n_lines":2},{"id":7911391,"accession":"0001764013-23-000117","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001764013-23-000117","line_url":"/filing/0001764013-23-000117","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796309","owner_name":"Salzmann Peter","owner_display_name":"Salzmann Peter","owner_url":"/insider/0001796309","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5239.0,"shares_display":"5,239","price_per_share":36.24495323535026,"price_display":"36.24","price_state":"stated","total_value":189887.31,"total_display":"189,887.31","total_whole":"189,887","shares_owned_after":964726.0,"shares_owned_after_display":"964,726","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-05","filed_date":"2023-10-06","scope":"insider","n_lines":2},{"id":8738538,"accession":"0001764013-23-000107","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001764013-23-000107","line_url":"/filing/0001764013-23-000107","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796309","owner_name":"Salzmann Peter","owner_display_name":"Salzmann Peter","owner_url":"/insider/0001796309","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":56774.0,"shares_display":"56,774","price_per_share":22.023071476380032,"price_display":"22.02","price_state":"stated","total_value":1250337.86,"total_display":"1,250,337.86","total_whole":"1,250,338","shares_owned_after":975873.0,"shares_owned_after_display":"975,873","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-30","filed_date":"2023-09-01","scope":"insider","n_lines":2},{"id":8717504,"accession":"0001764013-23-000094","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001764013-23-000094","line_url":"/filing/0001764013-23-000094","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796309","owner_name":"Salzmann Peter","owner_display_name":"Salzmann Peter","owner_url":"/insider/0001796309","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":103058.0,"shares_display":"103,058","price_per_share":21.416847988511325,"price_display":"21.42","price_state":"stated","total_value":2207177.52,"total_display":"2,207,177.52","total_whole":"2,207,178","shares_owned_after":1038053.0,"shares_owned_after_display":"1,038,053","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-14","filed_date":"2023-08-16","scope":"insider","n_lines":2},{"id":7823465,"accession":"0001764013-23-000087","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-23-000087","line_url":"/filing/0001764013-23-000087#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796309","owner_name":"Salzmann Peter","owner_display_name":"Salzmann Peter","owner_url":"/insider/0001796309","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":101339.0,"shares_display":"101,339","price_per_share":21.73,"price_display":"21.73","price_state":"stated","total_value":2202096.47,"total_display":"2,202,096.47","total_whole":"2,202,096","shares_owned_after":1129797.0,"shares_owned_after_display":"1,129,797","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-07","filed_date":"2023-08-08","scope":"insider"},{"id":8565647,"accession":"0001764013-23-000078","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-23-000078","line_url":"/filing/0001764013-23-000078#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796309","owner_name":"Salzmann Peter","owner_display_name":"Salzmann Peter","owner_url":"/insider/0001796309","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3233.0,"shares_display":"3,233","price_per_share":19.73,"price_display":"19.73","price_state":"stated","total_value":63787.09,"total_display":"63,787.09","total_whole":"63,787","shares_owned_after":1231136.0,"shares_owned_after_display":"1,231,136","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-12","filed_date":"2023-07-13","scope":"insider"},{"id":7953373,"accession":"0001764013-23-000049","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-23-000049","line_url":"/filing/0001764013-23-000049#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796309","owner_name":"Salzmann Peter","owner_display_name":"Salzmann Peter","owner_url":"/insider/0001796309","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3395.0,"shares_display":"3,395","price_per_share":15.27,"price_display":"15.27","price_state":"stated","total_value":51841.65,"total_display":"51,841.65","total_whole":"51,842","shares_owned_after":1234369.0,"shares_owned_after_display":"1,234,369","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-18","filed_date":"2023-04-19","scope":"insider"},{"id":8379419,"accession":"0001764013-23-000012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-23-000012","line_url":"/filing/0001764013-23-000012#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796309","owner_name":"Salzmann Peter","owner_display_name":"Salzmann Peter","owner_url":"/insider/0001796309","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4021.0,"shares_display":"4,021","price_per_share":16.8,"price_display":"16.80","price_state":"stated","total_value":67552.8,"total_display":"67,552.80","total_whole":"67,553","shares_owned_after":993932.0,"shares_owned_after_display":"993,932","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-11","filed_date":"2023-01-13","scope":"insider"},{"id":6561891,"accession":"0001764013-22-000130","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-22-000130","line_url":"/filing/0001764013-22-000130#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796309","owner_name":"Salzmann Peter","owner_display_name":"Salzmann Peter","owner_url":"/insider/0001796309","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2793.0,"shares_display":"2,793","price_per_share":9.18,"price_display":"9.18","price_state":"stated","total_value":25639.74,"total_display":"25,639.74","total_whole":"25,640","shares_owned_after":997953.0,"shares_owned_after_display":"997,953","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-13","filed_date":"2022-10-17","scope":"insider"},{"id":6363581,"accession":"0001764013-22-000122","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-22-000122","line_url":"/filing/0001764013-22-000122#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796309","owner_name":"Salzmann Peter","owner_display_name":"Salzmann Peter","owner_url":"/insider/0001796309","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1605.0,"shares_display":"1,605","price_per_share":4.67,"price_display":"4.67","price_state":"stated","total_value":7495.35,"total_display":"7,495.35","total_whole":"7,495","shares_owned_after":1000746.0,"shares_owned_after_display":"1,000,746","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-28","filed_date":"2022-09-29","scope":"insider"},{"id":6707516,"accession":"0001764013-22-000112","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-22-000112","line_url":"/filing/0001764013-22-000112#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796309","owner_name":"Salzmann Peter","owner_display_name":"Salzmann Peter","owner_url":"/insider/0001796309","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1644.0,"shares_display":"1,644","price_per_share":5.83,"price_display":"5.83","price_state":"stated","total_value":9584.52,"total_display":"9,584.52","total_whole":"9,585","shares_owned_after":1002351.0,"shares_owned_after_display":"1,002,351","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-30","filed_date":"2022-09-01","scope":"insider"},{"id":6561888,"accession":"0001764013-22-000077","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-22-000077","line_url":"/filing/0001764013-22-000077#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796309","owner_name":"Salzmann Peter","owner_display_name":"Salzmann Peter","owner_url":"/insider/0001796309","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1528.0,"shares_display":"1,528","price_per_share":4.27,"price_display":"4.27","price_state":"stated","total_value":6524.56,"total_display":"6,524.56","total_whole":"6,525","shares_owned_after":552731.0,"shares_owned_after_display":"552,731","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-27","filed_date":"2022-07-29","scope":"insider"},{"id":6379058,"accession":"0001764013-22-000072","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-22-000072","line_url":"/filing/0001764013-22-000072#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796309","owner_name":"Salzmann Peter","owner_display_name":"Salzmann Peter","owner_url":"/insider/0001796309","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1376.0,"shares_display":"1,376","price_per_share":4.02,"price_display":"4.02","price_state":"stated","total_value":5531.52,"total_display":"5,531.52","total_whole":"5,532","shares_owned_after":554259.0,"shares_owned_after_display":"554,259","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-29","filed_date":"2022-07-01","scope":"insider"},{"id":6707511,"accession":"0001764013-22-000045","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-22-000045","line_url":"/filing/0001764013-22-000045#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796309","owner_name":"Salzmann Peter","owner_display_name":"Salzmann Peter","owner_url":"/insider/0001796309","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1471.0,"shares_display":"1,471","price_per_share":3.79,"price_display":"3.79","price_state":"stated","total_value":5575.09,"total_display":"5,575.09","total_whole":"5,575","shares_owned_after":555635.0,"shares_owned_after_display":"555,635","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-24","filed_date":"2022-05-25","scope":"insider"},{"id":6136567,"accession":"0001764013-22-000041","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-22-000041","line_url":"/filing/0001764013-22-000041#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796309","owner_name":"Salzmann Peter","owner_display_name":"Salzmann Peter","owner_url":"/insider/0001796309","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1622.0,"shares_display":"1,622","price_per_share":4.72,"price_display":"4.72","price_state":"stated","total_value":7655.84,"total_display":"7,655.84","total_whole":"7,656","shares_owned_after":557106.0,"shares_owned_after_display":"557,106","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-27","filed_date":"2022-04-29","scope":"insider"},{"id":6260968,"accession":"0001764013-22-000035","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-22-000035","line_url":"/filing/0001764013-22-000035#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796309","owner_name":"Salzmann Peter","owner_display_name":"Salzmann Peter","owner_url":"/insider/0001796309","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19227.0,"shares_display":"19,227","price_per_share":5.9,"price_display":"5.90","price_state":"stated","total_value":113439.3,"total_display":"113,439.30","total_whole":"113,439","shares_owned_after":558728.0,"shares_owned_after_display":"558,728","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-24","filed_date":"2022-04-14","scope":"insider"},{"id":6910004,"accession":"0001764013-22-000009","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-22-000009","line_url":"/filing/0001764013-22-000009#line-1","is_derivative":false,"issuer_cik":"0001764013","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001764013","owner_cik":"0001796309","owner_name":"Salzmann Peter","owner_display_name":"Salzmann Peter","owner_url":"/insider/0001796309","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":125158.0,"shares_display":"125,158","price_per_share":7.25,"price_display":"7.25","price_state":"stated","total_value":907395.5,"total_display":"907,395.50","total_whole":"907,396","shares_owned_after":577955.0,"shares_owned_after_display":"577,955","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-07","filed_date":"2022-01-11","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":41,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":41,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":41},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001764013","name":"Immunovant, Inc.","url":"/issuer/0001764013","role":"Director, Officer (Chief Executive Officer)","n_filings":33,"first_seen":"2022-01-11","last_seen":"2025-04-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001796309","retrieved_at":"2026-08-24T01:39:12+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}